Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oncology Adjuvants market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Adjuvantsmarket, defines the market attractiveness level of Oncology Adjuvants market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncology Adjuvants industry, describes the types of Oncology Adjuvants market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Adjuvants market and the development prospects and opportunities of Oncology Adjuvants industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Adjuvants market in Chapter 13.
By Player:
Biogen
AstraZeneca
Eli Lilly
Sanofi
BMS
Amgen
Pfizer
By Type:
Radiotherapy
Chemotherapy
Immunotherapy
Hormone therapy
Targeted therapy
Others
By End-User:
Cancer Research Institutes
Cancer Hospitals
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncology Adjuvants Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncology Adjuvants Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncology Adjuvants Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncology Adjuvants Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncology Adjuvants Market Analysis and Outlook to 2022
-
7.1 Global Oncology Adjuvants Consumption (2017-2022)
-
7.2 United States Oncology Adjuvants Consumption (2017-2022)
-
7.3 Europe Oncology Adjuvants Consumption (2017-2022)
-
7.4 China Oncology Adjuvants Consumption (2017-2022)
-
7.5 Japan Oncology Adjuvants Consumption (2017-2022)
-
7.6 India Oncology Adjuvants Consumption (2017-2022)
-
7.7 South Korea Oncology Adjuvants Consumption (2017-2022)
8 Region and Country-wise Oncology Adjuvants Market Analysis and Outlook to 2028
-
8.1 Global Oncology Adjuvants Consumption Forecast (2022-2028)
-
8.2 United States Oncology Adjuvants Consumption Forecast (2022-2028)
-
8.3 Europe Oncology Adjuvants Consumption Forecast (2022-2028)
-
8.4 China Oncology Adjuvants Consumption Forecast (2022-2028)
-
8.5 Japan Oncology Adjuvants Consumption Forecast (2022-2028)
-
8.6 India Oncology Adjuvants Consumption Forecast (2022-2028)
-
8.7 South Korea Oncology Adjuvants Consumption Forecast (2022-2028)
9 Global Oncology Adjuvants Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology Adjuvants Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hormone therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Targeted therapy Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology Adjuvants Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Hospitals Consumption and Growth Rate (2017-2022)
10 Global Oncology Adjuvants Market Outlook by Types and Applications to 2028
-
10.1 Global Oncology Adjuvants Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Hormone therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncology Adjuvants Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Hospitals Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncology Adjuvants Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncology Adjuvants Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncology Adjuvants Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncology Adjuvants Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncology Adjuvants Market Competitive Analysis
-
14.1 Biogen
-
14.1.1 Biogen Company Details
-
14.1.2 Biogen Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Oncology Adjuvants Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Oncology Adjuvants Product and Service
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Details
-
14.3.2 Eli Lilly Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly Oncology Adjuvants Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Oncology Adjuvants Product and Service
-
14.5 BMS
-
14.5.1 BMS Company Details
-
14.5.2 BMS Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BMS Oncology Adjuvants Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Oncology Adjuvants Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Oncology Adjuvants Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncology Adjuvants
-
Figure Oncology Adjuvants Picture
-
Table Global Oncology Adjuvants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Adjuvants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Adjuvants Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncology Adjuvants Consumption by Country (2017-2022)
-
Figure United States Oncology Adjuvants Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure China Oncology Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure India Oncology Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Adjuvants Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncology Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncology Adjuvants Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncology Adjuvants Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Oncology Adjuvants Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oncology Adjuvants Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Oncology Adjuvants Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oncology Adjuvants Product and Service
-
Table BMS (Foundation Year, Company Profile and etc.)
-
Table BMS Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table BMS Oncology Adjuvants Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Oncology Adjuvants Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Oncology Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Oncology Adjuvants Product and Service
-
